Improving Lives Through Nuclear Medicine™

Contact

Frequently Asked Questions

Click on a question to reveal the answer.

  • You can reach our Customer Service at 1-888-633-5343 from 8:00 AM to 5:00 PM EST, Monday through Friday or leave a message after hours.

  • To report an Adverse Event on one of our products, please refer to the following contact information:

    Phone: 1-888-633-5343 or 514-630-7080 – choose option #1

    Fax:     1-866-431-4288 or 514-694-3865

    E-mail:  pharmacovigilance@jdi.jubl.com

    You can also visit our Adverse Events page in the Contact Us section of our Web site.

  • You can place your order anytime using our Customer Service electronic address:

    customerservice@jdi.jubl.com

  • Canada: ground or air, next day delivery

    United States: Federal Express, next day delivery

    Elsewhere in the world: Federal Express or country preferred carrier

  • To reach us after hours, please dial 1-888-633-5343 or 514-630-7080 and choose from the following options:

    1- report an Adverse Event

    2- Transportation Emergency

    3- Question about your order

    4- Urgent question relative to the quality of our product

    5- Leave a message or place an order

    6- Other inquire requiring immediate assistance

  • New Year (3 days), Good Firday, Victoria Day, Jean-Baptiste Day (June 24), Canada Day (July 1), Labour Day, Thanksgiving Day, Christmas (3 days).

    For the exact dates, please consult the Holiday Calendar in the Contact Us Section of our Web site.

  • For general enquiries, to place an order or communicate a Purchase Order number, our FAX number is:

    1-866-431-4288 or 514-694-3865

  • Canada
    Jubilant DraxImage Inc.
    16751 TransCanada Highway
    Kirkland, Québec, Canada
    H9H 4J4

     

    India
    Jubilant DraxImage Limited
    1-A, Sector 16-A
    Noida – 201 301, UP
    India

We use cookies to recognize your repeat visits and preferences, as well as to measure the effectiveness
of campaigns and analyze traffic. If you continue to use this site we will assume your acceptance.